Opko Health Inc. (OPK) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Opko Health Inc. (OPK:NASDAQ), powered by AI.

Current Price
$1.39
P/E Ratio
-4.6
Market Cap
1.0B
Sector
Healthcare
What is the Opko Health Inc. stock price forecast?

Opko Health Inc. is currently trading at $1.39. View real-time AI analysis on Alpha Lenz.

What is Opko Health Inc. insider trading activity?

View the latest insider trading data for Opko Health Inc. on Alpha Lenz.

What is Opko Health Inc.'s P/E ratio?

Opko Health Inc.'s P/E ratio is -4.6.

Opko Health Inc.

NASDAQ · OPK
$1.39-0.01(-0.71%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Opko Health Inc.'s future dividend policy...
Alpha Chat Insight

Opko Health Inc. trades at a P/E of -4.6 (undervalued) with modest ROE of -17.1%.

Ask for details

Company Overview

Opko Health Inc. is a diversified healthcare company that operates in the pharmaceutical and diagnostics sectors. The company's primary mission is to achieve significant advances in diagnosing and treating complex medical conditions. With a robust portfolio, Opko Health engages in the development and commercialization of specialty pharmaceuticals across various therapeutic areas, including endocrinology, oncology, and infectious diseases. In the diagnostics segment, Opko provides innovative solutions and services aimed at improving patient outcomes through early detection of diseases and individualized treatment plans. A notable feature of Opko Health is its strong emphasis on research and development, partnering with biotechnology firms and leveraging cutting-edge technology to bring novel healthcare solutions to market. Operating both in the United States and internationally, Opko's influence extends across the medical landscape as it strives to enhance healthcare delivery and access. Through its multifaceted operations, the company plays a pivotal role in pushing the boundaries of medical science and improving patient care on a global scale.

CEODr. Phillip Frost M.D., Ph.D.
SectorHealthcare
IndustryDiagnostics & Research
Employees2,997

Company Statistics

FY 2025

Profile

$1.04BMarket Cap
$606.88MRevenue
0.00Shares Out
2,997Employees

Margins

33.93%Gross
-23.47%EBITDA
-36.08%Operating
-39.77%Pre-Tax
-37.19%Net

Valuation

-4.63P/E
0.82P/B
1.72EV/Sales
-7.53EV/EBITDA
-5.47P/FCF

Growth (CAGR)

-15.45%Rev 3Yr
-15.82%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-10.92%ROA
-17.14%ROE
-6.43%ROIC

Financial Health

$369.07MCash & Cash Equivalents
$294.91MNet Debt
52.37%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Opko Health Inc. (ticker: OPK) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 2,997 employees. Market cap is $1.0B.

The current price is $1.39 with a P/E ratio of -4.63x and P/B of 0.82x.

ROE is -17.14% and operating margin is -36.08%. Annual revenue is $607M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Opko Health Inc. (OPK) Stock Forecast 2026 $1.39 — Price, Financials & Analyst Targets | Alpha Lenz